Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

NCT: NCT05907564 · ACTIVE_NOT_RECRUITING

NCT IDNCT05907564
StatusACTIVE_NOT_RECRUITING
Start Date2023-09-20
Completion2027-02
SponsorInquis Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

Frequently Asked Questions

What is Aventus Thrombectomy System Pulmonary Embolism Clinical Study?

Aventus Thrombectomy System Pulmonary Embolism Clinical Study is a clinical trial registered under NCT05907564. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05907564?

The current status of NCT05907564 (Aventus Thrombectomy System Pulmonary Embolism Clinical Study) is: ACTIVE_NOT_RECRUITING.

When did Aventus Thrombectomy System Pulmonary Embolism Clinical Study start?

Aventus Thrombectomy System Pulmonary Embolism Clinical Study started on 2023-09-20.

Related Devices

K232730Aventus Thrombectomy SystemInquis Medical K250202Aventus Thrombectomy SystemInquis Medical K251189Aventus Thrombectomy SystemInquis Medical K253925Aventus Thrombectomy SystemInquis Medical K262030Aventus Thrombectomy SystemInquis Medical

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑